These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 28539285

  • 21. Serum human epididymal protein 4 (HE4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin.
    Stiekema A, Boldingh QJ, Korse CM, van der Noort V, Boot H, van Driel WJ, Kenter GG, Lok CA.
    Gynecol Oncol; 2015 Mar; 136(3):562-6. PubMed ID: 25560808
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis.
    Zhang L, Chen Y, Wang K.
    Curr Probl Cancer; 2019 Apr; 43(2):135-144. PubMed ID: 30017407
    [Abstract] [Full Text] [Related]

  • 25. HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study.
    Romagnolo C, Leon AE, Fabricio ASC, Taborelli M, Polesel J, Del Pup L, Steffan A, Cervo S, Ravaggi A, Zanotti L, Bandiera E, Odicino FE, Scattolo N, Squarcina E, Papadakis C, Maggino T, Gion M.
    Gynecol Oncol; 2016 May; 141(2):303-311. PubMed ID: 26801941
    [Abstract] [Full Text] [Related]

  • 26. Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer.
    Park Y, Kim Y, Lee EY, Lee JH, Kim HS.
    Int J Cancer; 2012 Mar 01; 130(5):1136-44. PubMed ID: 21484794
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Exosomal biomarkers in the differential diagnosis of ovarian tumors: the emerging roles of CA125, HE4, and C5a.
    Shi H, Liu L, Deng X, Xing X, Zhang Y, Djouda Rebecca Y, Han L.
    J Ovarian Res; 2024 Jan 05; 17(1):4. PubMed ID: 38178252
    [Abstract] [Full Text] [Related]

  • 32. Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review.
    Dochez V, Caillon H, Vaucel E, Dimet J, Winer N, Ducarme G.
    J Ovarian Res; 2019 Mar 27; 12(1):28. PubMed ID: 30917847
    [Abstract] [Full Text] [Related]

  • 33. HE4, CA125, the Risk of Malignancy Algorithm and the Risk of Malignancy Index and complex pelvic masses - a prospective comparison in the pre-operative evaluation of pelvic masses in an Australian population.
    Richards A, Herbst U, Manalang J, Pather S, Saidi S, Tejada-Berges T, Tan K, Williams P, Carter J.
    Aust N Z J Obstet Gynaecol; 2015 Oct 27; 55(5):493-7. PubMed ID: 26172511
    [Abstract] [Full Text] [Related]

  • 34. Diagnostic performance of human epididymis protein 4 compared to a combination of biophysical and biochemical markers to differentiate ovarian endometriosis from epithelial ovarian cancer in premenopausal women.
    Nikolova T, Zivadinovic R, Evtimovska N, Klisarovska V, Stanojevic M, Georgievska J, Nikolova N.
    J Obstet Gynaecol Res; 2017 Dec 27; 43(12):1870-1879. PubMed ID: 29027715
    [Abstract] [Full Text] [Related]

  • 35. The clinical value of the combined detection of sEGFR, CA125 and HE4 for epithelial ovarian cancer diagnosis.
    Li Y, Wang ZC, Luo L, Mu CY, Xu J, Feng Q, Li SB, Gu B, Ma P, Lan T.
    Eur Rev Med Pharmacol Sci; 2020 Jan 27; 24(2):604-610. PubMed ID: 32016961
    [Abstract] [Full Text] [Related]

  • 36. The utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosis.
    Kadija S, Stefanovic A, Jeremic K, Radojevic MM, Nikolic L, Markovic I, Atanackovic J.
    Int J Gynecol Cancer; 2012 Feb 27; 22(2):238-44. PubMed ID: 22214964
    [Abstract] [Full Text] [Related]

  • 37. Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses.
    Terlikowska KM, Dobrzycka B, Witkowska AM, Mackowiak-Matejczyk B, Sledziewski TK, Kinalski M, Terlikowski SJ.
    J Ovarian Res; 2016 Jul 19; 9(1):43. PubMed ID: 27436085
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients.
    Braicu EI, Krause CL, Torsten U, Mecke H, Richter R, Hellmeyer L, Lanowska M, Müller B, Koch E, Boenneß-Zaloum J, Ames K, Chekerov R, Hasenbein K, Zimmermann M, Mangler M, Chen F, Tauber R, Sehouli J.
    BMC Cancer; 2022 Jul 30; 22(1):831. PubMed ID: 35907794
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.